PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
403,000
+2,500 (0.62%)
Dec 30, 2025, 3:30 PM KST
57.73%
Market Cap4.19T
Revenue (ttm)496.03B
Net Income (ttm)151.24B
Shares Out10.39M
EPS (ttm)14,523.95
PE Ratio27.75
Forward PE23.96
Dividend1,100.00 (0.27%)
Ex-Dividend DateDec 29, 2025
Volume74,720
Average Volume112,175
Open400,000
Previous Close400,500
Day's Range396,000 - 409,000
52-Week Range233,500 - 713,000
Beta0.54
RSI47.56
Earnings DateFeb 6, 2026

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 497
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2024, PharmaResearch's revenue was 350.12 billion, an increase of 34.14% compared to the previous year's 261.01 billion. Earnings were 92.04 billion, an increase of 20.24%.

Financial Statements

News

There is no news available yet.